ORCHESTRA BIOMED HOLDINGS, INC. SALES AGREEMENTSales Agreement • August 12th, 2024 • Orchestra BioMed Holdings, Inc. • Surgical & medical instruments & apparatus • New York
Orchestra BioMed Holdings, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through TD Securities (USA) LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), having an aggregate offering price of up to $100,000,000 on the terms set forth in this agreement (this “Agreement”).
